Skip to content

Navan, Inc. NAVN Loss on fair value adjustments

Loss on fair value adjustments at other companies

Navitas Semiconductor Corporation logo
Navitas Semiconductor CorporationNVTS
-$7.91M-198%
Ligand Pharmaceuticals logo
Ligand PharmaceuticalsLGND
-$49.23M
Sphere Entertainment logo
Sphere EntertainmentSPHR
-$79K+84.8%
Blue Owl Technology Finance Corp. logo
Blue Owl Technology Finance Corp.OTF
-$494.28M-2,315%
Hut 8 Mining Corp. logo
Hut 8 Mining Corp.HUT
-$661K-158%
Coeur Mining logo
Coeur MiningCDE
$0+100%

Other financials

Income statement

See full
Revenue$220.2M+39.9%
Gross profit$163.1M+45.9%
Operating income-$18.1M-13.9%
Net income-$20.5M+66.5%
EPS (diluted)-$0.08+94.0%

Balance sheet

See full
Cash & equivalents$645.0M+70.1%
Total debt$172.5M
Total equity$1.2B+204%
Total assets$1.7B

Cash flow

See full
Operating cash flow-$6.8M-249%
CapEx$105.0K+16.7%
Free cash flow-$6.9M-255%

Valuation

See full
Market cap$5.57B
Enterprise value$5.1B
P/S7.3×

Profitability

See full
Gross margin72.1%
Operating margin-26%
Net margin-46.7%
FCF margin-41.5%

Returns & leverage

See full
Return on equity-1,572.6%
Debt / equity0.1×
Current ratio4.3×

Where this comes from

Reported directly by Navan, Inc. in its filing.

Tagged under the XBRL concept navn:FairValueAdjustmentOfWarrantsAndDerivatives.

The official record: Navan, Inc. ’s 10-Q, filed June 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Navan, Inc. 's loss on fair value adjustments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Navan, Inc. 's loss on fair value adjustments?
Navan, Inc. (NAVN) reported loss on fair value adjustments of $0 in Q1 2026.
How has Navan, Inc. 's loss on fair value adjustments changed year-over-year?
Navan, Inc. 's loss on fair value adjustments increased by 100.0% year-over-year, from -$10.14M to $0.
What does loss on fair value adjustments mean?
This metric represents the non-cash gains or losses resulting from the periodic revaluation of financial instruments, such as warrants, embedded derivatives, or other equity-linked contracts. These adjustments reflect changes in the fair market value of these instruments based on fluctuations in the company's stock price, volatility, and other market-based inputs. It serves as an indicator of the potential impact of complex financial structures on the company's reported net income, independent of core operational performance.